Stratifies risk in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency using C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, and MCT supplementation adequacy.
Stratifies risk in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency using C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, and MCT supplementation adequacy
Each component has a specific meaning:
Note: Interpret the vlcad risk score result against the thresholds and context described above.
Enter the C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, MCT supplementation adequacy for the scenario you are assessing. Stratifies risk in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency using C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, and MCT supplementation adequacy. Use the vlcad risk score result to inform your calculation.